Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testavan (FE 999303) in Adult Hypogonadal Males
NCT01665599Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Jul 2012
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of Itnogen in Hypogonadism, sponsored by Ferring Pharmaceuticals. Started Jul 2012; status: completed.
02
Drugs
Itnogen
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT01665599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01665599.